Free Trial

Twin Capital Management Inc. Buys 14,912 Shares of Colgate-Palmolive Company (NYSE:CL)

Colgate-Palmolive logo with Consumer Staples background

Twin Capital Management Inc. raised its stake in Colgate-Palmolive Company (NYSE:CL - Free Report) by 466.0% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 18,112 shares of the company's stock after purchasing an additional 14,912 shares during the period. Twin Capital Management Inc.'s holdings in Colgate-Palmolive were worth $1,697,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. Personal CFO Solutions LLC bought a new position in shares of Colgate-Palmolive during the 1st quarter worth about $285,000. Aviva PLC increased its position in shares of Colgate-Palmolive by 13.4% during the 4th quarter. Aviva PLC now owns 973,421 shares of the company's stock worth $88,494,000 after purchasing an additional 114,855 shares in the last quarter. Vision Capital Management Inc. acquired a new stake in shares of Colgate-Palmolive during the 1st quarter worth about $322,000. Autumn Glory Partners LLC increased its position in shares of Colgate-Palmolive by 67.4% during the 1st quarter. Autumn Glory Partners LLC now owns 8,905 shares of the company's stock worth $851,000 after purchasing an additional 3,586 shares in the last quarter. Finally, Financial Gravity Asset Management Inc. acquired a new stake in shares of Colgate-Palmolive during the 1st quarter worth about $2,166,000. 80.41% of the stock is owned by institutional investors.

Colgate-Palmolive Stock Down 0.4%

NYSE:CL opened at $86.88 on Monday. The firm's 50 day simple moving average is $90.34 and its 200 day simple moving average is $90.38. The company has a debt-to-equity ratio of 8.96, a current ratio of 0.85 and a quick ratio of 0.54. Colgate-Palmolive Company has a one year low of $85.32 and a one year high of $109.30. The company has a market cap of $70.41 billion, a PE ratio of 24.54, a P/E/G ratio of 4.59 and a beta of 0.37.

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its quarterly earnings results on Friday, April 25th. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.86 by $0.05. Colgate-Palmolive had a net margin of 14.52% and a return on equity of 461.04%. The firm had revenue of $4.91 billion during the quarter, compared to analyst estimates of $4.92 billion. During the same quarter last year, the business earned $0.86 EPS. The company's revenue was down 3.0% compared to the same quarter last year. On average, research analysts anticipate that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 15th. Shareholders of record on Friday, July 18th will be paid a dividend of $0.52 per share. The ex-dividend date is Friday, July 18th. This represents a $2.08 dividend on an annualized basis and a yield of 2.39%. Colgate-Palmolive's dividend payout ratio (DPR) is presently 58.76%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on the stock. Barclays increased their target price on shares of Colgate-Palmolive from $86.00 to $87.00 and gave the stock an "equal weight" rating in a research report on Tuesday, July 15th. Wall Street Zen cut shares of Colgate-Palmolive from a "buy" rating to a "hold" rating in a research report on Wednesday, May 7th. Piper Sandler dropped their target price on shares of Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating for the company in a research report on Monday, March 31st. Wells Fargo & Company increased their target price on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the stock an "underweight" rating in a research report on Wednesday, April 2nd. Finally, JPMorgan Chase & Co. increased their target price on shares of Colgate-Palmolive from $95.00 to $103.00 and gave the stock an "overweight" rating in a research report on Monday, April 28th. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and seven have assigned a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $100.64.

View Our Latest Stock Analysis on Colgate-Palmolive

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Articles

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL - Free Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Colgate-Palmolive Right Now?

Before you consider Colgate-Palmolive, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.

While Colgate-Palmolive currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why Drone Stocks Are Skyrocketing Right Now!
Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters
This Strategy Beat the S&P—And Most Investors Ignore It

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines